FindTrial
Sign In

the clinical outcome of three ovarian stimulations in high progesterone milieu for normalovulatory patients undergoing IVF/ICSI cycles

clinical outcome of three ovarian stimulations in high progesterone milieu for normalovulatory patients undergoing IVF/ICSI cycles

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-14005577
Enrollment
Unknown
Registered
2014-11-07
Start date
2014-11-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

HMG and letrozole in luteal phase:HMG and letrozole
HMG and CC in luteal phase:HMG AND CC
HMG+MPA in follicular phase:HMG+MPA

Sponsors

Shanghai Nineth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
24 Years to 40 Years

Inclusion criteria

Inclusion criteria: 25-40y, regular ovulation, FSH less than 10IU/L and AFC 5-15.

Exclusion criteria

Exclusion criteria: ovarian failure, pcos and severe endometrosis, acute genital tract infection and other systemtic diseases.

Design outcomes

Primary

MeasureTime frame
the number of oocyte retrieval;—

Secondary

MeasureTime frame
the number of mature oocytes;the number of fertilized oocytes;the number of viable embryos;incidence of premature OHSS;—

Countries

China

Contacts

Public ContactYanping Kuang
kuangyanp@126.com+86 021-53078080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026